Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

Core Viewpoint - Kamada Ltd. has received a tax ruling from the Israel Tax Authority regarding a cash dividend of $0.25 per share, totaling approximately $14.4 million, which is set to be paid on April 7, 2026, to shareholders of record as of March 23, 2026 [1] Tax Ruling and Dividend Details - The tax ruling allows eligible Nasdaq shareholders from countries with a tax treaty with Israel to benefit from a reduced withholding tax rate on the dividend [2] - Israeli corporate shareholders may qualify for an exemption from Israeli withholding tax under the ruling [2][6] Withholding Tax Procedures - The current Israeli withholding tax rate is 30% for substantial shareholders and 25% for other shareholders [5] - On the payment date, 25% of the dividend will be withheld and remitted to the tax agent, with the remaining 75% distributed to shareholders [6] - Nasdaq shareholders must submit required documentation to the tax agent by May 9, 2026, to claim the reduced withholding tax rate [6][9] Documentation Requirements - Required documentation includes bank account details, identification, proof of residency, and declarations regarding share ownership and tax residency [6][7] - Non-Israeli corporate shareholders must provide additional documentation regarding their shareholders or partners [7][13] Company Overview - Kamada Ltd. is a global biopharmaceutical company focused on rare and serious conditions, with a portfolio of FDA-approved specialty plasma-derived products [11] - The company aims for growth through organic expansion, distribution partnerships, plasma collection operations, and potential mergers and acquisitions [11]